China Metabotropic Glutamate Receptor 4 Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Metabotropic Glutamate Receptor 4 market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Metabotropic Glutamate Receptor 4 market. Detailed analysis of key players, along with key growth strategies adopted by Metabotropic Glutamate Receptor 4 industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Domain Therapeutics SA

    • Prexton Therapeutics SA

    • Addex Therapeutics Ltd

    By Type:

    • VU-0418506

    • ADX-88178

    • JBPOS-0101

    • PXT-2331

    • Others

    By End-User:

    • Anxiety Disorders

    • Autism

    • Depression

    • Drug Addiction

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Metabotropic Glutamate Receptor 4 Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of VU-0418506 from 2016 to 2027

    • 1.3.2 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of ADX-88178 from 2016 to 2027

    • 1.3.3 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of JBPOS-0101 from 2016 to 2027

    • 1.3.4 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of PXT-2331 from 2016 to 2027

    • 1.3.5 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Anxiety Disorders from 2016 to 2027

    • 1.4.2 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Autism from 2016 to 2027

    • 1.4.3 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Depression from 2016 to 2027

    • 1.4.4 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Drug Addiction from 2016 to 2027

    • 1.4.5 China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Metabotropic Glutamate Receptor 4 Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Metabotropic Glutamate Receptor 4 by Major Types

    • 3.4.1 Market Size and Growth Rate of VU-0418506

    • 3.4.2 Market Size and Growth Rate of ADX-88178

    • 3.4.3 Market Size and Growth Rate of JBPOS-0101

    • 3.4.4 Market Size and Growth Rate of PXT-2331

    • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Metabotropic Glutamate Receptor 4 Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Metabotropic Glutamate Receptor 4 by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Metabotropic Glutamate Receptor 4 in Anxiety Disorders

    • 4.4.2 Market Size and Growth Rate of Metabotropic Glutamate Receptor 4 in Autism

    • 4.4.3 Market Size and Growth Rate of Metabotropic Glutamate Receptor 4 in Depression

    • 4.4.4 Market Size and Growth Rate of Metabotropic Glutamate Receptor 4 in Drug Addiction

    • 4.4.5 Market Size and Growth Rate of Metabotropic Glutamate Receptor 4 in Others

    5 Market Analysis by Regions

    • 5.1 China Metabotropic Glutamate Receptor 4 Production Analysis by Regions

    • 5.2 China Metabotropic Glutamate Receptor 4 Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Metabotropic Glutamate Receptor 4 Landscape Analysis

    • 6.1 North China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major Types

    • 6.2 North China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major End-Users

    7 Central China Metabotropic Glutamate Receptor 4 Landscape Analysis

    • 7.1 Central China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major Types

    • 7.2 Central China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major End-Users

    8 South China Metabotropic Glutamate Receptor 4 Landscape Analysis

    • 8.1 South China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major Types

    • 8.2 South China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major End-Users

    9 East China Metabotropic Glutamate Receptor 4 Landscape Analysis

    • 9.1 East China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major Types

    • 9.2 East China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major End-Users

    10 Northeast China Metabotropic Glutamate Receptor 4 Landscape Analysis

    • 10.1 Northeast China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major Types

    • 10.2 Northeast China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major End-Users

    11 Southwest China Metabotropic Glutamate Receptor 4 Landscape Analysis

    • 11.1 Southwest China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major Types

    • 11.2 Southwest China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major End-Users

    12 Northwest China Metabotropic Glutamate Receptor 4 Landscape Analysis

    • 12.1 Northwest China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major Types

    • 12.2 Northwest China Metabotropic Glutamate Receptor 4 Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Domain Therapeutics SA

      • 13.1.1 Domain Therapeutics SA Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Prexton Therapeutics SA

      • 13.2.1 Prexton Therapeutics SA Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Addex Therapeutics Ltd

      • 13.3.1 Addex Therapeutics Ltd Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of VU-0418506 from 2016 to 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of ADX-88178 from 2016 to 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of JBPOS-0101 from 2016 to 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of PXT-2331 from 2016 to 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Anxiety Disorders from 2016 to 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Autism from 2016 to 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Depression from 2016 to 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Drug Addiction from 2016 to 2027

    • Figure China Metabotropic Glutamate Receptor 4 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Metabotropic Glutamate Receptor 4 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Metabotropic Glutamate Receptor 4 Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Metabotropic Glutamate Receptor 4

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Metabotropic Glutamate Receptor 4 by Different Types from 2016 to 2027

    • Table Consumption Share of Metabotropic Glutamate Receptor 4 by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of VU-0418506

    • Figure Market Size and Growth Rate of ADX-88178

    • Figure Market Size and Growth Rate of JBPOS-0101

    • Figure Market Size and Growth Rate of PXT-2331

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Metabotropic Glutamate Receptor 4 by Different End-Users from 2016 to 2027

    • Table Consumption Share of Metabotropic Glutamate Receptor 4 by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Anxiety Disorders

    • Figure Market Size and Growth Rate of Autism

    • Figure Market Size and Growth Rate of Depression

    • Figure Market Size and Growth Rate of Drug Addiction

    • Figure Market Size and Growth Rate of Others

    • Table China Metabotropic Glutamate Receptor 4 Production by Regions

    • Table China Metabotropic Glutamate Receptor 4 Production Share by Regions

    • Figure China Metabotropic Glutamate Receptor 4 Production Share by Regions in 2016

    • Figure China Metabotropic Glutamate Receptor 4 Production Share by Regions in 2021

    • Figure China Metabotropic Glutamate Receptor 4 Production Share by Regions in 2027

    • Table China Metabotropic Glutamate Receptor 4 Consumption by Regions

    • Table China Metabotropic Glutamate Receptor 4 Consumption Share by Regions

    • Figure China Metabotropic Glutamate Receptor 4 Consumption Share by Regions in 2016

    • Figure China Metabotropic Glutamate Receptor 4 Consumption Share by Regions in 2021

    • Figure China Metabotropic Glutamate Receptor 4 Consumption Share by Regions in 2027

    • Table North China Metabotropic Glutamate Receptor 4 Consumption by Types from 2016 to 2027

    • Table North China Metabotropic Glutamate Receptor 4 Consumption Share by Types from 2016 to 2027

    • Figure North China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2016

    • Figure North China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2021

    • Figure North China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2027

    • Table North China Metabotropic Glutamate Receptor 4 Consumption by End-Users from 2016 to 2027

    • Table North China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users from 2016 to 2027

    • Figure North China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2016

    • Figure North China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2021

    • Figure North China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2027

    • Table Central China Metabotropic Glutamate Receptor 4 Consumption by Types from 2016 to 2027

    • Table Central China Metabotropic Glutamate Receptor 4 Consumption Share by Types from 2016 to 2027

    • Figure Central China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2016

    • Figure Central China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2021

    • Figure Central China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2027

    • Table Central China Metabotropic Glutamate Receptor 4 Consumption by End-Users from 2016 to 2027

    • Table Central China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2016

    • Figure Central China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2021

    • Figure Central China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2027

    • Table South China Metabotropic Glutamate Receptor 4 Consumption by Types from 2016 to 2027

    • Table South China Metabotropic Glutamate Receptor 4 Consumption Share by Types from 2016 to 2027

    • Figure South China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2016

    • Figure South China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2021

    • Figure South China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2027

    • Table South China Metabotropic Glutamate Receptor 4 Consumption by End-Users from 2016 to 2027

    • Table South China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users from 2016 to 2027

    • Figure South China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2016

    • Figure South China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2021

    • Figure South China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2027

    • Table East China Metabotropic Glutamate Receptor 4 Consumption by Types from 2016 to 2027

    • Table East China Metabotropic Glutamate Receptor 4 Consumption Share by Types from 2016 to 2027

    • Figure East China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2016

    • Figure East China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2021

    • Figure East China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2027

    • Table East China Metabotropic Glutamate Receptor 4 Consumption by End-Users from 2016 to 2027

    • Table East China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users from 2016 to 2027

    • Figure East China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2016

    • Figure East China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2021

    • Figure East China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2027

    • Table Northeast China Metabotropic Glutamate Receptor 4 Consumption by Types from 2016 to 2027

    • Table Northeast China Metabotropic Glutamate Receptor 4 Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2016

    • Figure Northeast China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2021

    • Figure Northeast China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2027

    • Table Northeast China Metabotropic Glutamate Receptor 4 Consumption by End-Users from 2016 to 2027

    • Table Northeast China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2016

    • Figure Northeast China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2021

    • Figure Northeast China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2027

    • Table Southwest China Metabotropic Glutamate Receptor 4 Consumption by Types from 2016 to 2027

    • Table Southwest China Metabotropic Glutamate Receptor 4 Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2016

    • Figure Southwest China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2021

    • Figure Southwest China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2027

    • Table Southwest China Metabotropic Glutamate Receptor 4 Consumption by End-Users from 2016 to 2027

    • Table Southwest China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2016

    • Figure Southwest China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2021

    • Figure Southwest China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2027

    • Table Northwest China Metabotropic Glutamate Receptor 4 Consumption by Types from 2016 to 2027

    • Table Northwest China Metabotropic Glutamate Receptor 4 Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2016

    • Figure Northwest China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2021

    • Figure Northwest China Metabotropic Glutamate Receptor 4 Consumption Share by Types in 2027

    • Table Northwest China Metabotropic Glutamate Receptor 4 Consumption by End-Users from 2016 to 2027

    • Table Northwest China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2016

    • Figure Northwest China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2021

    • Figure Northwest China Metabotropic Glutamate Receptor 4 Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Domain Therapeutics SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Domain Therapeutics SA

    • Figure Sales and Growth Rate Analysis of Domain Therapeutics SA

    • Figure Revenue and Market Share Analysis of Domain Therapeutics SA

    • Table Product and Service Introduction of Domain Therapeutics SA

    • Table Company Profile and Development Status of Prexton Therapeutics SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prexton Therapeutics SA

    • Figure Sales and Growth Rate Analysis of Prexton Therapeutics SA

    • Figure Revenue and Market Share Analysis of Prexton Therapeutics SA

    • Table Product and Service Introduction of Prexton Therapeutics SA

    • Table Company Profile and Development Status of Addex Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addex Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Addex Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Addex Therapeutics Ltd

    • Table Product and Service Introduction of Addex Therapeutics Ltd


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.